Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study.

Cognitive function Cord blood transplantation Human herpesvirus-6B Memory function

Journal

International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627

Informations de publication

Date de publication:
26 Feb 2024
Historique:
received: 24 10 2023
accepted: 16 01 2024
revised: 19 12 2023
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: aheadofprint

Résumé

This prospective multicenter study aimed to determine the effects of human herpesvirus-6B (HHV-6B) reactivation on central nervous system (CNS) function in cord blood transplant (CBT) recipients. Our focus was to track HHV-6B reactivation and evaluate its association with delirium and cognitive function, specifically in the domains of verbal memory, attention/processing speed, and quality of life (QOL). A cohort of 38 patients participated in this study. Of the 37 patients evaluated, seven (18.9%) developed delirium, with six of these cases emerging after HHV-6B reactivation (median lag, 7 days). Evaluation of verbal memory showed that the final trial score for unrelated words at 70 days after transplantation was significantly lower than that before preconditioning (P = 0.004) among patients (n = 15) who experienced higher-level HHV-6B reactivation (median or higher maximum plasma HHV-6 DNA load for participating patients). Patients without higher-level reactivation did not show significant declines in verbal memory scores. QOL was assessed using the 36-item Short-Form Health Survey, and the social functioning score 1 year post-transplantation was significantly lower in patients who experienced higher-level HHV-6B reactivation than in those who did not. Our findings suggest that higher-level HHV-6B reactivation can detrimentally affect certain cognitive functions in CBT recipients.

Identifiants

pubmed: 38407786
doi: 10.1007/s12185-024-03714-2
pii: 10.1007/s12185-024-03714-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP17K09090

Informations de copyright

© 2024. The Author(s).

Références

Zerr DM, Corey L, Kim HW, Huang ML, Nguy L, Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2005;40:932–40.
doi: 10.1086/428060 pubmed: 15824982
Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H, et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis. 2013;57:671–81.
doi: 10.1093/cid/cit358 pubmed: 23723198
Zerr DM, Fann JR, Breiger D, Boeckh M, Adler AL, Xie H, et al. HHV-6 reactivation and its effect on delirium and cognitive functioning in hematopoietic cell transplantation recipients. Blood. 2011;117:5243–9.
doi: 10.1182/blood-2010-10-316083 pubmed: 21389320 pmcid: 3109545
Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G, et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood. 2002;100:2005–11.
doi: 10.1182/blood.V100.6.2005 pubmed: 12200359
Ogata M, Kikuchi H, Satou T, Kawano R, Ikewaki J, Kohno K, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis. 2006;193:68–79.
doi: 10.1086/498531 pubmed: 16323134
Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci. 2001;1:229–42.
doi: 10.1176/jnp.13.2.229
Japan Society for Higher Brian Dysfunction (2014) Standard verbal paired-associate learning test. Shinkoigakushuppansha, Tokyo (in Japanese)
Fukuda T, Ohnuma T, Obara K, Kondo S, Arai H, Ano Y. Supplementation with matured hop bitter acids improves cognitive performance and mood state in healthy older adults with subjective cognitive decline. J Alzheimers Dis. 2020;76:387–98.
doi: 10.3233/JAD-200229 pubmed: 32474473 pmcid: 7369117
Wechsler D. Wechsler adult intelligence scale-third edition. San Antonio: The Psychological Corporation; 1997.
Fujita K, Maekawa H, Dairoku K, Yamanaka K. A Japanese version of the Wechsler Adult Intelligence Scale-Third Edition. Tokyo: Nihon Bunka Kagakusha; 2006.
Fujino H, Sumiyoshi C, Sumiyoshi T, Yasuda Y, Yamamori H, Ohi K, et al. Performance on the Wechsler Adult Intelligence Scale-III in Japanese patients with schizophrenia. Psychiatry Clin Neurosci. 2014;68:534–41.
doi: 10.1111/pcn.12165 pubmed: 24447376
Suzukamo Y, Fukuhara S, Green J, Kosinski M, Gandek B, Ware JE. Validation testing of a three-component model of Short Form-36 scores. J Clin Epidemiol. 2011;64:301–8.
doi: 10.1016/j.jclinepi.2010.04.017 pubmed: 20800993
Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol. 1998;51:1037–44.
doi: 10.1016/S0895-4356(98)00095-X pubmed: 9817121
McQuellon RP, Russell GB, Cella DF, Craven BL, Brady M, Bonomi A, et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant. 1997;19:357–68.
doi: 10.1038/sj.bmt.1700672 pubmed: 9051246
Kato M, Kishi Y, Okuyama T, Trzepacz PT, Hosaka T. Japanese version of the Delirium Rating Scale, Revised-98 (DRS-R98-J): reliability and validity. Psychosomatics. 2010;51:425–31.
pubmed: 20833942
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1994;15:825–8.
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–56.
doi: 10.1016/j.bbmt.2005.09.004 pubmed: 16338616
Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.
doi: 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O pubmed: 10204198
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
doi: 10.1038/bmt.2012.244 pubmed: 23208313
Hill JA, Boeckh M, Leisenring WM, Xie H, Adler AL, Huang ML, et al. Human herpesvirus 6B reactivation and delirium are frequent and associated events after cord blood transplantation. Bone Marrow Transplant. 2015;50:1348–51.
doi: 10.1038/bmt.2015.154 pubmed: 26121112 pmcid: 4486349
Ward KN, Hill JA, Hubacek P, Camara R, Crocchiolo R, Einsele H, et al. Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation. Haematologica. 2019;104:2155–63.
doi: 10.3324/haematol.2019.223073 pubmed: 31467131 pmcid: 6821622

Auteurs

Masao Ogata (M)

Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University, Hasama-Machi, Yufu, Oita, 879-5593, Japan. mogata@oita-u.ac.jp.
Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University, Oita, Japan. mogata@oita-u.ac.jp.

Kumi Oshima (K)

Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kanagawa, Japan.

Kuniko Takano (K)

Department of Hematology, Oita University Hospital, Oita, Japan.

Rie Kawano (R)

Department of Hematology, Oita University Hospital, Oita, Japan.

Yasunori Ueda (Y)

Department of Hematology/Oncology, Kurashiki Central Hospital, Okayama, Japan.

Takashi Imamura (T)

Department of Clinical Psychology, Kurashiki Central Hospital, Okayama, Japan.

Yukinori Nakamura (Y)

Third Department of Internal Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan.

Takahiro Okada (T)

Department of Hematology, Shimane University Hospital, Shimane, Japan.

Tomomi Toubai (T)

Division of Hematology and Cell Therapy, Department of Internal Medicine III, Faculty of Medicine, Yamagata University, Yamagata, Japan.

Toshimitsu Ueki (T)

Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan.

Nobuhiko Uoshima (N)

Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.

Hiroyuki Ishida (H)

Department of Pediatrics, Kyoto City Hospital, Kyoto, Japan.

Akihito Shinohara (A)

Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.

Sachiko Seo (S)

Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.

Takahiro Fukuda (T)

Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.

Masatoshi Inagaki (M)

Department of Psychiatry, Faculty of Medicine, Shimane University, Shimane, Japan.

Classifications MeSH